Exact Sciences Clarifies Colorectal Cancer Test Status, Touts Tech’s Benefits
This article was originally published in The Gray Sheet
Executive Summary
Exact Sciences and licensing partner LabCorp are newly committed to improving appreciation for stool-based DNA testing, confident that their PreGen-Plus colorectal cancer screening assay meets FDA criteria as a "homebrew" exempt from agency oversight